C

Catalyst Pharmaceuticals
D

CPRX

21.520
USD
0.25
(1.18%)
Market Open
Volume
15,704
EPS
2
Div Yield
-
P/E
18
Market Cap
2,566,764,343
OverviewSignalsIdeasNews
Related Instruments
    A
    ADMP
    0
    (0%)
    0.000000 USD
    A
    ANIP
    0.250
    (0.47%)
    53.670 USD
    A
    ARWR
    0.300
    (1.54%)
    19.750 USD
    E
    ERYP
    -0.02670
    (-3.45%)
    0.70000 USD
    I
    INO
    -0.04500
    (-2.46%)
    1.78500 USD
    K
    KPTI
    -0.01940
    (-3.01%)
    0.62490 USD
    M
    MRTX
    0
    (0%)
    0.000000 USD
    R
    RARE
    -0.850
    (-1.92%)
    43.340 USD
    More
News

Title: Catalyst Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.